- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02344381
The Impact of Sucrose Ingestion Post-Exercise on Liver and Muscle Glycogen Repletion.
Carbohydrate is stored in the body as glycogen, which is mainly found in the liver and muscle. During endurance exercise, muscle glycogen is used as fuel for the working muscles and liver glycogen is broken down to provide glucose to maintain blood glucose (sugar) levels. Both liver and muscle glycogen are important for our ability to perform intense/prolonged endurance exercise. Therefore, it is important to replete these stores after an intense/prolonged endurance exercise session in order to recover and perform optimally during a subsequent exercise bout, especially if the next exercise session is within 24h (e.g. stage races such as the Tour de France, tournament-style competitions such as the Olympic games and ultra-endurance events).
Carbohydrate intake has been shown to increase the availability of glycogen in the muscle and liver after exercise. The carbohydrates typically found in sports drinks are glucose and sometimes fructose. It has been observed that the ingestion of glucose will lead to a maximum rate of absorption of approximately ~1 g/min. However, if we also provide a different source of carbohydrate (fructose) then this is absorbed through a different pathway and therefore we can absorb up to ~1.75 g/min of carbohydrate. In addition, both carbohydrate sources are metabolised differently in the human body. By supplementing both glucose and fructose, we can potentially replenish the liver and muscle glycogen stores at a faster rate than ingestion of glucose only.
Sucrose is a naturally occurring sugar that is made up of a single glucose and single fructose molecule. Therefore, theoretically, this can use the two different pathways of absorption and also maximise carbohydrate delivery. It is not yet known however, what impact this has on our liver and muscle glycogen stores post-exercise when supplemented in relatively high amounts. Therefore the aim of this study is to assess whether relative high amounts of sucrose ingestion will improve liver and muscle glycogen repletion after endurance exercise.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North East
-
Newcastle upon Tyne, North East, United Kingdom, NE1 8ST
- Northumbria University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy
- Endurance trained cyclists/triathletes
- VO2 max ≥ 50 ml/kg/min
Exclusion Criteria:
- Use of medication
- Smoking
- Metabolic disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sucrose
Sucrose ingestion post-exercise
|
|
|
Active Comparator: Glucose
Glucose ingestion post-exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in liver glycogen concentration
Time Frame: 5 h
|
The change in liver glycogen content will be determined post-exercise using 13C magnetic resonance spectroscopy
|
5 h
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in muscle glycogen concentration
Time Frame: 5 h
|
The change in muscle glycogen content will be determined post-exercise using 13C magnetic resonance spectroscopy
|
5 h
|
|
Plasma glucose concentration
Time Frame: 5 h
|
5 h
|
|
|
Plasma insulin concentration
Time Frame: 5 h
|
5 h
|
|
|
Plasma lactate concentration
Time Frame: 5 h
|
5 h
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NorthumbriaU
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver and Muscle Glycogen Replenishment Post-exercise
-
Javier Gonzalez, PhDMaastricht University; University of Newcastle Upon-Tyne; Sugar Nutrition, UKCompletedLiver and Muscle Glycogen Use During Exercise.United Kingdom
-
University of Nove de JulhoMulti Radiance MedicalCompletedPost-exercise Muscle RecoveryBrazil
-
Maastricht University Medical CenterUnknownCarbohydrate Oxidation and Glycogen Utilization During and Following ExerciseNetherlands
-
University of TaipeiCompletedExercise Training | Skeletal Muscle Recovery | Post-menopausal Women | Bone Marrow Stem CellsTaiwan
-
RDC Clinical Pty LtdCompletedMuscle Pain | Muscle Fatigue | Exercise Recovery | Post Exercise InflammationAustralia
-
Catherine MikusCompleted
-
Lindenwood UniversityArcher Daniels Midland Co.Not yet recruitingHealthy | Oxidative Stress | Exercise Performance | Immune Function | Exercise-induced Muscle Damage | Gut Health | Exercise-induced Muscle Soreness | Microbiome Analysis | Exercise MetabolismUnited States
-
University of Sistan and BaluchestanCompletedAthletic Injuries | Muscle Recovery | Exercise-induced Muscle Damage | Delayed-Onset Muscle Soreness (DOMS)Iran
-
Metabolic Technologies Inc.University of TampaCompletedMuscle Fatigue Caused by Repetitive Muscle ExerciseUnited States
-
Lancaster UniversityNot yet recruitingMuscle Fatigue Caused by Repetitive Muscle ExerciseUnited Kingdom
Clinical Trials on Glucose
-
University of Texas Southwestern Medical CenterCompletedSarcoma | Neuroblastoma | Pediatric CancerUnited States
-
Stanford UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Suspended
-
Children's Mercy Hospital Kansas CityWithdrawnType 1 DiabetesUnited States
-
University of Massachusetts, WorcesterRecruitingPregnancy, High Risk | Type 2 Diabetes Treated With InsulinUnited States
-
Glostrup University Hospital, CopenhagenUnknown
-
Makassed General HospitalCompleted
-
Unilever R&DLeiden University Medical CenterCompleted
-
US Department of Veterans AffairsEmory UniversityCompletedType 2 Diabetes Mellitus | Prediabetic StateUnited States